Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Blood
|
August 22, 2025
Remestemcel-L-rknd (Ryoncil): the first approved cellular therapy for steroid-refractory acute GVHD
Aaron M Etra, James L M Ferrara, John E Levine
Transplantation and Cellular Therapy
|
March 8, 2024
Defining and Grading Infections in Clinical Trials Involving Hematopoietic Cell Transplantation: A Report From the BMT CTN Infectious Disease Technical Committee
Zainab Shahid, Aaron M Etra, John E Levine, et al.
Blood Immunology & Cellular Therapy
|
May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM
Yu Akahoshi, Nikolaos Katsivelos, Ioannis E Louloudis, et al.
Transplantation and Cellular Therapy
|
December 12, 2024
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group
Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, et al.
Blood Advances
|
July 1, 2025
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC
Yu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, et al.
Blood Advances
|
December 22, 2020
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin
Stephanie C Gergoudis, Zachariah DeFilipp, Umut Özbek, et al.
Transplantation and Cellular Therapy
|
September 27, 2025
Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity
Ioannis Evangelos Louloudis, Yi-Bin Chen, Nikolaos Spyrou, et al.
Transplantation and Cellular Therapy
|
September 2, 2024
Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients
Carlos A Ortega Rios, Muna Qayed, Aaron M Etra, et al.
Blood
|
July 5, 2024
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD
Yu Akahoshi, Nikolaos Spyrou, Daniela Weber, et al.
Blood Advances
|
February 7, 2024
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis
Yu Akahoshi, Nikolaos Spyrou, Matthias Hoepting, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Blood
|
August 22, 2025
Remestemcel-L-rknd (Ryoncil): the first approved cellular therapy for steroid-refractory acute GVHD
Aaron M Etra, James L M Ferrara, John E Levine
Transplantation and Cellular Therapy
|
March 8, 2024
Defining and Grading Infections in Clinical Trials Involving Hematopoietic Cell Transplantation: A Report From the BMT CTN Infectious Disease Technical Committee
Zainab Shahid, Aaron M Etra, John E Levine, et al.
Blood Immunology & Cellular Therapy
|
May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM
Yu Akahoshi, Nikolaos Katsivelos, Ioannis E Louloudis, et al.
Transplantation and Cellular Therapy
|
December 12, 2024
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group
Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, et al.
Blood Advances
|
July 1, 2025
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC
Yu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, et al.
Blood Advances
|
December 22, 2020
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin
Stephanie C Gergoudis, Zachariah DeFilipp, Umut Özbek, et al.
Transplantation and Cellular Therapy
|
September 27, 2025
Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity
Ioannis Evangelos Louloudis, Yi-Bin Chen, Nikolaos Spyrou, et al.
Transplantation and Cellular Therapy
|
September 2, 2024
Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients
Carlos A Ortega Rios, Muna Qayed, Aaron M Etra, et al.
Blood
|
July 5, 2024
Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD
Yu Akahoshi, Nikolaos Spyrou, Daniela Weber, et al.
Blood Advances
|
February 7, 2024
Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis
Yu Akahoshi, Nikolaos Spyrou, Matthias Hoepting, et al.
Page
of 2